Cancer Management Archives - Well Referenced

Active Surveillance for Low-Risk Prostate Cancer-An Evolving International Standard of Care

This article explores the evolving role of active surveillance in the management of low-risk prostate cancer. The study reviews international guidelines and clinical outcomes, highlighting the benefits of active surveillance in avoiding overtreatment and preserving quality of life. It emphasizes that with proper patient selection and monitoring, active surveillance is

June 26, 2025 No Comments

Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data

This review examines the role of active surveillance in the management of intermediate-risk prostate cancer. The study evaluates current data on the effectiveness of active surveillance as an alternative to immediate aggressive treatment, focusing on factors such as tumor characteristics, patient age, and overall health. The review concludes that active

June 26, 2025 No Comments

A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer

This commentary discusses the use of PSA (prostate-specific antigen) velocity and doubling time as critical factors in making clinical decisions for prostate cancer management. The article examines how changes in PSA levels over time can indicate tumor progression and help guide treatment decisions. It emphasizes the importance of incorporating PSA

June 26, 2025 No Comments

Active Surveillance for Intermediate Risk Prostate Cancer

This article reviews the role of active surveillance in managing intermediate-risk prostate cancer. It examines current evidence supporting the use of active surveillance for this patient group, considering factors like tumor characteristics, patient age, and life expectancy. The study suggests that active surveillance can be a reasonable alternative to aggressive

June 26, 2025 No Comments

Active Surveillance for Low-Risk Cancers – A Viable Solution to Overtreatment?

This article discusses the use of active surveillance as a strategy to manage low-risk cancers and avoid overtreatment. It explores the benefits of closely monitoring patients with low-risk cancer types, such as prostate and thyroid cancers, rather than pursuing immediate aggressive treatments. The study suggests that active surveillance can reduce

June 26, 2025 No Comments

Tag: Cancer Management

Active Surveillance for Low-Risk Prostate Cancer-An Evolving International Standard of Care

Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data

A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer

Active Surveillance for Intermediate Risk Prostate Cancer

Active Surveillance for Low-Risk Cancers – A Viable Solution to Overtreatment?